Board of Directors

Independent Consultant

Mr. Lubran is a consultant on projects focusing on prevention, treatment, and recovery from opioid use disorders including development of a medication assisted treatment (MAT) mobile application. He also reviews use cases involving integrated Medicare and Medicaid data to profile providers’ opioid prescribing patterns specific to dual eligibles, recruits sites to participate in a CDC funded national evaluation of MAT services, reviews a national MAT curriculum, and conducts SAMHSA grant reviews. Mr. Lubran is a also a board member of Stop Stigma Now, and the National Alliance of Medication Assisted Recovery, as well as a member of the American Society of Addiction Medicine. From 1997 to 2016, he led the SAMHSA opioid treatment regulatory program, which included certification of opioid addiction treatment programs and approval of physicians to prescribe buprenorphine. Other accomplishments included leading SAMHSA’s hepatitis prevention activities; directing the MAT Treatment Improvement Protocol (TIPS) series; and heading up the Agency’s global addiction efforts under the President’s Emergency Plan for AIDS Relief.

Duties:

The Board of Director Chairman is responsible for the governing body, overseeing the vision, mission, and internal operations of the organization. In addition, the board chair is responsible to direct the members of the board. The board chair also serves as the direct liaison between the board and management. Board members serve as ambassadors for Danya Institute's mission, inside and outside of organizational commitments.

Sharon Dow has over 40 years of experience in policy development, planning, technical assistance, and direct provision of substance abuse and mental health services, with 22 years of involvement in writing, interpreting, and management of federal and state grants and contracts. Ms. Dow also understands the addiction treatment system from a provider’s point of view, having directed development for Colonial Management Group, LP, one of the largest private providers of opiate treatment. Her expertise in policy development, technical assistance, substance abuse treatment, and State systems allowed the Joint Commission (JC) to be in the forefront of the Substance Abuse and Mental Health Administration’s (SAMHSA) policy initiative requiring accreditation of all opiate treatment programs. She directed the Opioid Addiction Treatment Improvement Project (OATIP), a SAMHSA funded contract which focused on providing technical assistance to Single State Agencies and opioid addiction treatment programs in the areas of policy, regulation development, interagency relationships and counselor training. Ms. Dow was recruited to be the Project Director for OATIP from her position as Chief of the Program and Policy Development Division of Maryland’s Alcohol and Drug Abuse Administration, where she was responsible for policy development and interpretation, regulation development, and methadone treatment issues. She also served as the State’s Methadone Treatment Authority (SMA), currently referred to as State Opioid Treatment Authority (SOTA).

Duties:

Serves as a member of the board to govern, oversee the vision, mission, and internal operations of the organization.

Executive Director, NACBHDD

Dr. Manderscheid has been a member of The Danya Institute Board and became Chairman in 2019. He leads efforts to reform mental health and substance use care benefits in Medicare, Medicaid, and private insurance. His career spans the public, private, and academic sectors. He has served in numerous leadership roles at the National Institute of Mental Health (NIMH) and at the Substance Abuse and Mental Health Services Administration (SAMHSA). He served for many years on the faculty of the University of Maryland where he taught statistics, sociology, and social organization. He currently is the Executive Director of the National Association of County Behavioral Health and Developmental Disability Directors and is an Adjunct Professor in the Department of Mental Health at the Johns Hopkins University Bloomberg School of Public Health.

Duties:

Serves as a member of the board to govern, oversee the vision, mission, and internal operations of the organization.

Director of Health Equity, DHPE

Dr. Owens provides TA to state, local, and territorial departments of health to address health inequities through using public health systems and environmental change tools, and geographic analysis of market research data to plan and inform effective health programs. With an emphasis on health equity, Steven provides health department staff trainings on integrating social determinants of health into projects and activities addressing chronic disease prevention and health promotion. Additionally, he oversees the placement of DHPE’s health promotion and policy fellows at state departments of health. Prior to joining for DHPE, he led the Diversity Initiative for USAID’s Global Health Fellows Program. Steven received a master’s in biology from Hampton University, a master’s in public health with a focus on international health policy and management from Rollins School of Public Health at Emory University and a M.D. from the Brody School of Medicine at East Carolina University.

Duties:

Serves as a member of the board to govern, oversee the vision, mission, and internal operations of the organization.

Chief Financial Officer, Open Technology Group

Mr. Steiner founded Open Technology Group, a small business providing information technology services to federal government clients. Open Technology Group is committed to innovation and dedicated to improving the efficiency of government operations with secure, reliable, and sustainable technology solutions and numerous value-add services.

Duties:

In accordance with organizational bylaws, Mr. Steiner is primarily responsible for overseeing The Danya Institute’s finances.

Associate Professor, West Virginia University

Dr. Winstanley received her doctoral degree from The Johns Hopkins Bloomberg School of Public Health, she has postdoctoral training in behavioral pharmacology, and she has over 20 years of experience as a behavioral health services researcher. She is the Multiple Principal investigator (MPI) of the Appalachian Node of the NIDA Clinical Trials Network (CTN) and a Site PI for the Tailored Retention and Engagement for Equitable Treatment of OUD and Pain (TREETOP) clinical research center at the University of Pittsburgh (Pitt) which is part of the NIH IMPOWR network. Her current research is focused on reducing the morbidity and mortality associated with the overdose epidemic, as well as the use of technology to improve access and quality of behavioral health services. More specifically, she is investigating cognitive impairments and brain abnormalities that result from opioid-related overdose and problems initiating buprenorphine treatment among individuals using fentanyl

Duties:

Serves as a member of the board to govern, oversee the vision, mission, and internal operations of the organization.